Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuriaAbstracted from: Marre M, Lievre M, Chatellier G, et al. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004; 328(7438): 495–500.

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ ◽

10.1136/bmj.328.7441.686-b ◽

2004 ◽

Vol 328 (7441) ◽

pp. 686.3

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Controlled Trial ◽

Urinary Albumin ◽

Double Blind ◽

Double Blind Placebo ◽

Renal Outcomes

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ ◽

10.1136/bmj.37970.629537.0d ◽

2004 ◽

Vol 328 (7438) ◽

pp. 495 ◽

Cited By ~ 178

Author(s):

Michel Marre ◽

Michel Lievre ◽

Gilles Chatellier ◽

Johannes F E Mann ◽

Philippe Passa ◽

...

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Controlled Trial ◽

Urinary Albumin ◽

Double Blind ◽

Double Blind Placebo ◽

Renal Outcomes

Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735542506.793559665 ◽

2019 ◽

Author(s):

Carmine Zoccali ◽

Davide Bolignano

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Effect

Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial

Journal of Herbal Medicine ◽

10.1016/j.hermed.2019.100315 ◽

2020 ◽

Vol 20 ◽

pp. 100315

Author(s):

Hasan Gholinezhad ◽

Hadi Bazyar ◽

Homeira Rashidi ◽

Parvin Salehi ◽

Mohammad Hosein Haghighi-zadeh ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Chronic Periodontitis ◽

Controlled Trial ◽

Periodontal Therapy ◽

Double Blind ◽

Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.07.008 ◽

2012 ◽

Vol 34 (9) ◽

pp. 1909-1919.e15 ◽

Cited By ~ 37

Author(s):

Andrew J. Lewin ◽

Lisa Arvay ◽

Dacheng Liu ◽

Sanjay Patel ◽

Maximilian von Eynatten ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Double Blind ◽

The effects of vitamin D2 or D3supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial

BMC Public Health ◽

10.1186/1471-2458-13-999 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 3

Author(s):

Ravi K Menon ◽

Anna P Rickard ◽

Nasima Mannan ◽

Peter M Timms ◽

Stephen J Sharp ◽

...

Keyword(s):

Type 2 Diabetes ◽

At Risk ◽

Glycaemic Control ◽

Controlled Trial ◽

Metabolic Parameters ◽

Vitamin D2 ◽

Double Blind ◽

The Effects of Choline and Magnesium Co-Supplementation on Metabolic Parameters, Inflammation, and Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of the American College of Nutrition ◽

10.1080/07315724.2019.1599745 ◽

2019 ◽

Vol 38 (8) ◽

pp. 714-721 ◽

Cited By ~ 7

Author(s):

Samaneh Rashvand ◽

Majid Mobasseri ◽

Ali Tarighat-Esfanjani

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Endothelial Dysfunction ◽

Controlled Trial ◽

Metabolic Parameters ◽

Double Blind ◽

Administration of Herbarium Mixture (Guazuma ulmifolia/Tecoma stans) on Metabolic Profile in Type 2 Diabetes Mellitus Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of Medicinal Food ◽

10.1089/jmf.2020.0082 ◽

2020 ◽

Author(s):

Sara Pascoe-González ◽

María Guadalupe Ramos-Zavala ◽

Miguel Angel Buenrostro Ahued ◽

Sandra Ofelia Hernández-González ◽

Ernesto Germán Cardona-Muñoz ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Metabolic Profile ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Guazuma Ulmifolia

Oxidative stress and nitrate/nitrite (NOx) status following citrulline supplementation in type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial

Journal of Human Nutrition and Dietetics ◽

10.1111/jhn.12792 ◽

2020 ◽

Author(s):

S. Azizi ◽

M. Ebrahimi‐Mameghani ◽

M. Mobasseri ◽

N. Karamzad ◽

R. Mahdavi

Keyword(s):

Oxidative Stress ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Double Blind ◽

Aggressive Lipid Lowering Does Not Improve Endothelial Function in Type 2 Diabetes: The Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial

Diabetes Care ◽

10.2337/diacare.25.7.1211 ◽

2002 ◽

Vol 25 (7) ◽

pp. 1211-1216 ◽

Cited By ~ 74

Author(s):

F. V. van Venrooij ◽

M. A. van de Ree ◽

M. L. Bots ◽

R. P. Stolk ◽

M. V. Huisman ◽

...

Keyword(s):

Type 2 Diabetes ◽

Endothelial Function ◽

Controlled Trial ◽

Lipid Lowering ◽

Double Blind ◽